loader2
Partner With Us NRI

Sep 06, 2024


Category

Equity

AUM (Cr.)

8,139.57

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.82

Sharpe Ratio

25.42

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (G) 6.79 21.77 48.63 18.08 29.4 21.53
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS 5.27 18.81 41.81 20.01 24.28 21.58
Category Rank 7/4 6/4 6/4 7/4 7/4 4/4
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (IDCW) 10.5543 1.51 15.35 0.00 0.00 364.34 2.43 500.00 invest
Nippon India Taiwan Equity Fund (G) 10.5543 1.51 15.35 0.00 0.00 364.34 2.43 500.00 invest
Quant Healthcare Fund - Regular (G) 17.3620 0.23 61.27 0.00 0.00 348.91 2.37 5,000.00 invest
Quant Healthcare Fund - Regular (IDCW) 17.3633 0.23 61.27 0.00 0.00 348.91 2.37 5,000.00 invest
SBI PSU Fund (G) 32.9531 -2.31 67.86 38.86 28.38 4,601.76 1.87 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Aug 31, 2024 1,194.34 13.81 5.95
Equity-Lupin Aug 31, 2024 717.69 8.30 17.17
Equity-Divi`s Lab. Aug 31, 2024 688.09 7.96 3.47
Equity-Cipla Aug 31, 2024 513.02 5.93 7.16
Equity-Dr Reddy`s Labs Aug 31, 2024 492.22 5.69 4.16
Equity-Apollo Hospitals Aug 31, 2024 449.45 5.20 4.72
Equity-Ajanta Pharma Aug 31, 2024 311.16 3.60 20.35
Equity-Gland Pharma Aug 31, 2024 275.78 3.19 -14.15
Equity-Vijaya Diagnost. Aug 31, 2024 276.26 3.19 15.42
Equity-Aurobindo Pharma Aug 31, 2024 267.21 3.09 3.47

latest news

Nippon India Mutual Fund announces change in Key Personnel

Nippon India Mutual Fund has announced that Mr. Chetan Desai has been appoi...

Sep 02, 2024 10:25

Nippon India MF launches Nifty 500 Equal Weight Index Fund

Nippon India Mutual Fund has introduced the Nippon India Nifty 500 Equal We...

Aug 21, 2024 13:21

Nippon India MF announces change in Fund Manager of the following schemes

Nippon India Mutual Fund has announced change in Fund Managers of the follo...

Aug 17, 2024 10:59

Nippon India Mutual Fund files for Active Momentum Fund

Nippon India Mutual Fund has filed draft documents for Active Momentum Fund...

Aug 13, 2024 13:10

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 August 2024 as the record date fo...

Aug 12, 2024 09:28

Nippon India Mutual Fund announces change in Exit Load Structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Aug 05, 2024 11:02

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (G)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com